Michael Kenison
Corporate Officer/Principal bei PROTO LABS, INC.
Vermögen: 702 268 $ am 30.04.2024
Profil
Michael R.
Kenison is currently the Vice President & General Manager-Americas at Proto Labs, Inc. He previously worked as the Vice President-Manufacturing at Cardiac Science, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PROTO LABS, INC.
0,09% | 20.05.2024 | 22 351 ( 0,09% ) | 702 268 $ | 30.04.2024 |
Aktive Positionen von Michael Kenison
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTO LABS, INC. | Corporate Officer/Principal | 01.06.2021 |
Ehemalige bekannte Positionen von Michael Kenison
| Unternehmen | Position | Ende |
|---|---|---|
Cardiac Science, Inc.
 Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROTO LABS, INC. | Process Industries |
| Private Unternehmen | 1 |
|---|---|
Cardiac Science, Inc.
Cardiac Science, Inc. Miscellaneous Commercial ServicesCommercial Services Cardiac has developed RHYTHMx ECD, technology that continuously monitors a patient's heart rhythm and provided defibrillation to help the organ keep a steady beat. Cardiac Science has used the technology to develop an external cardiac defibrillator, the Powerheart, which is used in hospitals. The firm also sold patient monitors and emergency defibrillators, and has developed a small portable defibrillator that can be used by patients in the hospital or at home. Cardiac Science markets its products in more than 50 countries worldwide. | Commercial Services |
